Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Perrigo launches six-week TV campaign to promote Dermalex

Manufacturer Perrigo has launched a six-week TV campaign for its skincare brand Dermalex.

The campaign hits the airwaves today (October 23), with another series of advertisements to follow from November 20.

Perrigo is “excited” about the launch, said senior marketing director Holly Turner, as it will “showcase Dermalex to consumers as a product that is moisturising, protecting, and gentle on the skin”.

“Symptoms of skin conditions such as eczema, acne, psoriasis and rosacea can heighten insecurities and affect self-confidence,” she added.

Alongside the launch, Dermalex is partnering with independent pharmacy consultant Dr Christine Clark, as well as bloggers.

It has also created a Facebook page to give advice to patients with skin conditions.

The Dermalex range includes:

• Dermalex Atopic Eczema Treatment. RRP: 30g, £11.99; 100g, £24.99.

• Dermalex Rosacea Treatment. RRP: 30g, £18.99.

• Dermalex Psoriasis Scalp Gel. RRP: 75g, £18.99.

• Dermalex Acne Treatment. RRP: 30g, £18.99.

To order, contact Phoenix on 01928 750 500

Do you stock Perrigo products?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD009004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel